Hypoxia as a barrier to immunotherapy in pancreatic adenocarcinoma
Abstract Pancreatic ductal adenocarcinoma (PDA) is a lethal disease with limited response to cytotoxic chemoradiotherapy, as well as newer immunotherapies. The PDA tumor microenvironment contains infiltrating immune cells including cytotoxic T cells; however, there is an overall immunosuppressive mi...
Main Authors: | S. K. Daniel, K. M. Sullivan, K. P. Labadie, V. G. Pillarisetty |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-04-01
|
Series: | Clinical and Translational Medicine |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40169-019-0226-9 |
Similar Items
-
Overcoming tumor hypoxia as a barrier to radiotherapy, chemotherapy and immunotherapy in cancer treatment
by: Graham K, et al.
Published: (2018-10-01) -
Hypoxia Promotes Syndecan-3 Expression in the Tumor Microenvironment
by: Endika Prieto-Fernández, et al.
Published: (2020-09-01) -
Targeting hypoxia in the tumor microenvironment: a potential strategy to improve cancer immunotherapy
by: Bin Wang, et al.
Published: (2021-01-01) -
Exosomes and the Future of Immunotherapy in Pancreatic Cancer
by: Ines A. Batista, et al.
Published: (2019-01-01) -
Characterization of hypoxia response patterns identified prognosis and immunotherapy response in bladder cancer
by: Rui Cao, et al.
Published: (2021-09-01)